PUBLISHER: IMARC | PRODUCT CODE: 2024756
PUBLISHER: IMARC | PRODUCT CODE: 2024756
The global pregnancy detection kits market size reached USD 1.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.16% during 2026-2034. The increasing demand for self-detecting pregnancy kits, the introduction of advanced product variants, and the rising birth rate represent some of the key factors driving the market.
Pregnancy detection kits are diagnostics devices used for an early indication of pregnancy. They are manufactured using a lateral flow device (LFD) that contains different types of paper engineered with pores of various sizes. They comprise a test strip that consists of a result window, absorbent paper, and sample well and help detect the presence of reproductive hormones, including human chorionic gonadotropin (HCG), in the samples of urine and blood. They are cost-effective, easy to use, reliable, and provide results in a few minutes. Besides this, as they aid in detecting early pregnancy and promote social and emotional well-being, pregnancy detection kits are gaining traction across the globe. At present, product manufacturers are introducing digital pregnancy detection kits with weeks indicator.
There is an increase in awareness about the availability of pregnancy detection kits. This, couple with the numerous benefits associated with the early detection of the prenatal period, such as focusing on social and emotional well-being, represents one of the major factors strengthening the growth of the market around the world. Moreover, the growing adolescent pregnancy rate, rising birth rate, and the increasing number of unplanned pregnancies are some of the factors influencing the market positively. In addition, the increasing demand for home-based pregnancy detection kits to reduce the number of hospital visits and minimize healthcare expenses is contributing to the market growth. Apart from this, key players are focusing on promotional strategies, such as celebrity endorsements, banner and television advertisements and marketing in movie theaters to propel people for using pregnancy detection kits, thereby increasing their overall sales. Furthermore, the expansion of pharmacies across residential areas is propelling the growth of the market. Besides this, there is a rise in the number of online retail platforms that offer pregnancy detection kits at affordable rates and with easy accessibility through the comforts of the home. This, in confluence with significant growth in the pharmaceutical and e-commerce industries, is creating a positive outlook for the market. Additionally, rapid urbanization, rising global population, and expanding purchasing power of the consumer are driving the sales of pregnancy detection kits across the globe.
This report provides an analysis of the key trends in each segment of the global pregnancy detection kits market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on product, test type, and end user.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for pregnancy detection kits. Some of the factors driving the North America pregnancy detection kits market included increased availability of pregnancy detection kits, high government spending on quality healthcare, and an increase in unplanned pregnancies.
The report has also provided a comprehensive analysis of the competitive landscape in the global pregnancy detection kits market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Axis Medicare, bioMerieux SA (INSTITUT MERIEUX), Cardinal Health Inc., Church & Dwight Co. Inc., Germaine Laboratories Inc, Mankind Pharma, Piramal Enterprises, QuidelOrtho Corporation, Swiss Precision Diagnostics GmbH (Procter & Gamble Company), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.